| 產(chǎn)品名稱 | AG 013736 - Axitinib |
| 產(chǎn)品貨號(hào) | Axon 1414 CAS [319460-85-0] MF C22H18N4OSMW 386.47 Purity: 99% Soluble in DMSO Description A tyrosine kinase inhibitor (TKI), targeting VEGFR/PDGFR/c-KIT; orally bioavailable drug exerting an anti-angiogenic effect. KEYWORDS:?AG 013736 | supplier | VEGFR inhibitor | Axitinib | AG013736 | AG-013736 | AG-13736 | CAS [319460-85-0] | SCF | PDGF | VEGF | c-KIT | PDGFR | VEGFR | Tyrosine kinase inhibitor | TKI | RTK | orally bioavailable | anti-angiogenic |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
AG 013736 - AxitinibAxon 1414 CAS [319460-85-0] MF C22H18N4OS
DescriptionA tyrosine kinase inhibitor (TKI), targeting VEGFR/PDGFR/c-KIT; orally bioavailable drug exerting an anti-angiogenic effect. KEYWORDS:?AG 013736 | supplier | VEGFR inhibitor | Axitinib | AG013736 | AG-013736 | AG-13736 | CAS [319460-85-0] | SCF | PDGF | VEGF | c-KIT | PDGFR | VEGFR | Tyrosine kinase inhibitor | TKI | RTK | orally bioavailable | anti-angiogenic
PDGFR,c-KIT and VEGFR tyrosine kinase inhibitor
Chemical nameN-Methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide Source informationPfizer compound; Sold for research purposes under agreement from Pfizer Inc.Parent CAS No.[319460-85-0] |
| 產(chǎn)品資料 |
